MAP
CCXI

Moody Aldrich Partners’s ChemoCentryx, Inc. CCXI Stock Holding History

Moody Aldrich Partners’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-35,800
Closed -$1.83M – 204
2021
Q1 		$1.83M Buy
35,800
+640
+2% +$38.5K 0.26% 99
2020
Q4 		$2.18M Buy
35,160
+14,661
+72% +$839K 0.35% 88
2020
Q3 		$1.12M Buy
+20,499
New +$1.1M 0.23% 99

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Moody Aldrich Partners's CCXI Position: Q2 2021 in Review

Moody Aldrich Partners sold out of ChemoCentryx, Inc. (CCXI) in Q2 2021, closing a stake of 35,800 shares — an estimated $1.83M sold.

Moody Aldrich Partners first reported a position in CCXI in Q3 2020 and held it in 3 quarters. The position peaked at $2.18M in Q4 2020. 146 funds tracked by Wall St. Rank hold CCXI as of Q2 2021.

  • Moody Aldrich Partners reported no remaining ChemoCentryx, Inc. position as of Q2 2021 after selling out during the quarter.
  • Moody Aldrich Partners sold 35,800 ChemoCentryx, Inc. shares in Q2 2021, an estimated $1.83M.
  • Moody Aldrich Partners first reported a position in ChemoCentryx, Inc. in Q3 2020 and held it in 3 quarters.
  • Moody Aldrich Partners's ChemoCentryx, Inc. position peaked at $2.18M in Q4 2020.
  • 146 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2021.

Based on Moody Aldrich Partners's 13F filing for Q2 2021, filed 4 Aug 2021.